Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJID (2) Autor Manfredi,Roberto (1) Mendes,C.M.F. (1) Nicodemo,A.C. (1) Oplustil,C.P. (1) Sabbatani,Sergio (1) Sinto,S. (1) Mais... Palavra-chave Pneumococci (2) Characteristics (1) Clinical issues (1) Enterococci (1) Epidemiology (1) Literature evidences (1) Novel antimicrobial compounds (1) Resistant gram-positive cocci (1) Respiratory tract infections (1) S. pneumoniae antimicrobial resistance (1) Staphylococci (1) Streptococci (1) Susceptibility testing in vitro (1) Mais... Tipo do documento Info:eu-repo/semantics/article (2) Ano 2010 (1) 2001 (1) País Brazil (2) Idioma Inglês (2)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 2 Primeira ... 1 ... Última In vitro activity of fluoroquinolones (gatifloxacin, levofloxacin and trovafloxacin) and seven other antibiotics against Streptococcus pneumoniae BJID Nicodemo,A.C.; Mendes,C.M.F.; Oplustil,C.P.; Sinto,S.. In recent years, the level of resistance of S. pneumoniae to beta-lactam and/or macrolides has increased around the world including some countries in South America. Because of this resistance, it is necessary to test the therapeutic alternatives for treating this pathogen, including the newer quinolones. This study was carried out in order to compare the in vitro activity of fluoroquinolones gatifloxacin, levofloxacin and trovafloxacin, to penicillin G, amoxicillin, amoxicillin-clavulanate, cufuroxime sodium, ceftriaxone, azithromycin and clarithromycin, against 300 strains of S. pneumoniae. Of the 300 samples tested, 18.6% were not susceptible to penicillin (56 strains) and 7% (21 strains) were resistant to the second generation cephalosporin. Among the... Tipo: Info:eu-repo/semantics/article Palavras-chave: S. pneumoniae antimicrobial resistance; Susceptibility testing in vitro; Respiratory tract infections; Pneumococci. Ano: 2001 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702001000200001 Novel pharmaceutical molecules against emerging resistant gram-positive cocci BJID Manfredi,Roberto; Sabbatani,Sergio. INTRODUCTION: methicillin- and also vancomycin (glycopeptide)-resistant Gram-positive organisms have emerged as an increasingly problematic cause of hospital-acquired infections, also spreading into the community. Vancomycin (glycopeptide) resistance has emerged primarily among Enterococci, but the MIC values of vancomycin for the entire Staphylococcus species are also increasing worldwide. MATERIAL AND METHODS: the aim of our review is to evaluate the efficacy and tolerability of newer antibiotics with activity against methicillin-resistant and glycopeptide-resistant Gram-positive cocci, on the ground of our experience at a tertiary care metropolitan Hospital, and the most recent literature evidences in this field. RESULTS: Quinupristin-dalfopristin,... Tipo: Info:eu-repo/semantics/article Palavras-chave: Resistant gram-positive cocci; Staphylococci; Enterococci; Pneumococci; Streptococci; Epidemiology; Clinical issues; Novel antimicrobial compounds; Characteristics; Literature evidences. Ano: 2010 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000100020 Registros recuperados: 2 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco